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Abstract: Traditional models of hematopoiesis have been hierarchical in nature. Over the past 10 years, we have developed
data indicating that hematopoiesis is regulated in a continuum with deterministic and stochastic components. We have shown
that the most primitive stem cells, as represented by lineage negative rhodaminelow Hoechstlow murine marrow cells are
continuously or intermittently cycling as determined by in vivo BrdU labeling. When marrow stem cells are induced to transit
cell cycle by in vitro exposure to cytokines, either IL-3, IL-6, IL-11, and steel factor or thrombopoietin, FLT3 ligand, and steel
factor, they progress through cycle in a highly synchronized fashion. We have determined that when the stem cells progress
through a cytokine stimulated cell cycle the homing, engraftment, adhesion protein, global gene expression, and hematopoietic
differentiation phenotypes all change in a reversible fashion. This has led to the continuum model, in which, with cycle transit,
chromatin is continually changing altering open transcription areas and providing a continually changing landscape of
transcriptional opportunity. More recently, we have extended the changing differentiation profiles to differentiation into lung
cells and found that non-hematopoietic differentiation also shows cycle related reversibly modulation. These observations all
together support a continuum model of stem cell regulation in which the phenotype of the marrow stem cells is continually
and reversibly changing over time.
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Engraftment studies
A growing body of data has indicated that marrow
progenitor/stem cells are regulated on a continuum,
rather than in a hierarchy. This indicates that the pheno-
type of the marrow "stem cell" is labile and ever chang-
ing. These classes of cells can only be defined on a
population basis, not at a single cell level, since the
single cell will continuously and reversibly be changing
its functional, cell surface and gene expression pheno-
type.
Over the past 10 years, we have reported studies
showing that the marrow stem cell capacity varies with
phase of cell cycle and that this variation is not unidirec-
tional, rather it is reversible. Initial studies showed that
in vitro exposure to the cytokines interleukin-3 (IL-3),
IL-6, IL-11, and steel factor resulted in a loss of engraft-
ment after 48 hours of culture [10, 11]. When highly
purified lineage negative rhodaminelow Hoechstlow
(LRH) marrow cells were mapped through cell cycle, it
was shown that it took approximately 18 hours to reach
S-phase, and that the first cell cycle was completed by
36-38 hours [12]. Subsequent cell cycles were quite
rapid, being completed at 12 hour intervals for up to 5
cycles. More recent studies have shown that this popu-
lation, which is tightly synchronized by the cell separa-
tive procedure, shows up to 98% cells in S phase at one
point during the first cell cycle. A very prominent de-
crease in 8 week or 6 month engraftment was seen at 48
hours of cytokine culture. Subsequent studies showed
that there were reversible decreases in engraftment ca-
pacity which could occur at 2 to 4 hour intervals; a
prominent and reproducible decrease in engraftment
was seen to occur between 28-36 hours of culture, a time
representing late S/early G2 [7]. These studies were
particularly important, because they indicated that the
observed changes in the engraftment phenotype did not
represent an irreversible unidirectional differentiation
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step, but rather was a reversible variation which oc-
curred as the stem cells transited cell cycle.
Adhesion proteins and marrow homing
There followed studies on different adhesion proteins
showing reversible fluctuations of adhesion protein ex-
pression in both LRH and lineage negative Sca-1+ (Lin-
SCA-1+) marrow stem cells as they transited cell cycle.
Changes in VLA-4 showed the tightest correlation with
alterations in engraftment capacity [1, 2]. Further studies
indicated that marrow cell homing was markedly de-
pressed after 48 hours in IL-3, IL-6, IL-11 and steel
factor [4]. These studies indicated that marrow stem
cells exposed to cytokines in vitro modulated their ad-
hesion protein expression which led to alterations in
homing to marrow which in turn led to changes in short
and long-term engraftment. 
Progenitors and stem cell/progenitor
inversions
Further studies showed that marrow progenitor cells, as
represented by colony-forming unit culture (CFU-c) or
multifactor responsive high-proliferative potential col-
ony forming cells (HPP-CFC), also showed reversible
variations with cycle transit [6]. These studies were
carried out in culture with thrombopoietin, FLT3 li-
gand and steel factor (TFS) as the cytokines which
stimulated cell cycle transit. These progenitors gener-
ally showed increases when engraftment capacity was
decreased. We term these progenitor/stem cell inver-
sions. These studies suggested, although they did not
prove, that progenitors, as conventionally assayed,
and engraftable stem cells may simply be the same cell
showing different phenotypes at different points in a
cell cycle transit.
Cell cycle status of stem cells
The changes in stem cell phenotype with cell cycle
passage under cytokine stimulation, while of intrinsic
interest, would have less general biologic meaning if
marrow stem cells were truly quiescent non-cycling
cells. However, they are not. Important work by Brad-
ford and colleagues [3], confirmed by two other groups
[5, 9] showed that in vivo the most primitive "dormant"
stem cell class is in fact cycling. These investigators fed
mice BrdU in their drinking water and then isolated the
lineage-negative, rhodaminelow Hoechstlow (LRH) mar-
row stem cells at different times in the feeding schedule
and determined BrdU labeling of these stem cells. BrdU
is incorporated into DNA during DNA synthesis and,
thus, labeling with this agent is an accurate measure of
whether a cell has progressed through S-phase while
transiting the cell cycle. They found that 60% of these
primitive stem cells were labeled after 4 weeks and
showed a time to 50% labeling of 19 days. Cheshire
and colleagues [5] using a different mouse strain and
stem cell separation confirmed these data, showing
more rapid labeling kinetics. Our group investigated
whether DNA damage and repair might explain the
labeling, but after extensive studies came to the con-
clusion that BrdU incorporation did probably indicate
proliferation of these primitive stem cells over time
[9]. Thus, the most primitive stem cells are prolif-
erating in vivo over time and are presumably continu-
ously and reversibly changing their functional
phenotype over time.
Gene expression
Global gene expression was also evaluated in LRH
marrow stem cells at isolation and after 48 hours of
culture in IL-3, IL-6, IL-11, and steel factor, a time when
engraftment is reproducibly and reversibly depressed
[8]. To assess gene expression, we utilized a 3’ end-gene
display approach, which detects all sequences. Initially
we compared lineage positive cells to LRH stem cells.
We found 637 stem cell specific genes, of which 411
were unknown. While interpretation of individual gene
expression was difficult, especially given the number of
unknowns, we observed a dramatic inversion of gene
expression in the LRH cells at 48 hours. Genes which
were highly expressed at time 0 in LRH cells were
minimally expressed at 48 hours. Conversely, many
lowly expressed genes at time 0 were highly expressed
at 48 hours. In more recent studies, evaluating gene
expression by real-time PCR in LRH cells progressing
through a cytokine (TPO, FLT3L, and steel factor)
stimulated cell cycle, we observed marked fluctuations
in expression of certain cell surface markers, cytokine
receptors, and transcription factors. Genes which were
reversibly modulated included those coding for c-kit,
CD4, Sca-1, and SDF-1.
All of these observations weighed against a hierar-
chical model of stem/progenitor regulation and for a
continuum model. These studies are summarized in
Table 1.
Table 1. Phenotypic characteristics which reversibly modulate in
stem/progenitor cell with cell cycle transit
Six week and 6 month competitive engraftment capacity
Homing at 3 hours to marrow
Expression of surface adhesion proteins and genes coding for
these proteins
Stem cell progenitor inversions. Reversible increases in
progenitors tied to decreases in stem cells with cell cycle transit
Global gene expression as determined by 3"end gene display or
real-time PCR 
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Differentiation into hematopoietic and
non-hematopoietic lineages
The studies cited above indicate that the stem cell
changes phenotype with cell cycle passage. Cycling
cells continually change chromatin coverage and this, in
turn, will lead to different transcriptional control areas
being open to interaction with transcription complexes.
This is what presumably determines whether the cell
renews, proliferates, and/or differentiates. The cell
would in essence be continually presenting different
windows of transcriptional opportunity. Thus, a stem
cell transiting cell cycle and exposed to a constant cyto-
kine induction would show different outcomes at differ-
ent points in cycle. In order to test this hypothesis, we
structured experiments in which highly purified marrow
LRH cells were driven through cycle by exposure to
TPO, FLT3L, and steel factor and then subcultured in
GM-CSF, G-CSF, and steel factor at different times in
cycle. The final differentiation outcome was determined
14 days later. In these experiments, there was marked
induction of megakaryocyte differentiation in early S
phase. In additional experiments, using green-fluores-
cent protein positive congenic marrow cells and IL-3,
IL-6, IL-11, and steel factor as a stimulus for cycle
transit, the capacity of marrow cells to differentiate into
lung cells was assessed. In these experiments, GFP+
marrow cells engrafted into irradiated mice and then
later G-CSF mobilized mice showed a marked in-
crease in GFP+CD45 negative pulmonary events in
mid-S phase. Thus, differentiation in both the hema-
topoietic and non-hematopoietic pathways showed re-
versible cell cycle related modulation. The concept of
a stochastically deterministic continuum model is
presented in Figure 1.
Heterogeneity of a stem cell population
The continuum model of stem cell regulation implies
pronounced heterogeneity within the stem cell compart-
ment. This would be so because no matter how tightly
synchronized the stem cells may appear to be, using
tritiated thymidine or propidium studies, the synchrony
is not exact and, probably on a micro-time scale, most
freshly isolated purified stem cells will not be in exactly
the same phase of cycle, although most may be in early
G1 phase. When highly purified LRH marrow cells are
investigated for any functional attribute, these cells are
almost totally heterogeneous. For instance, when single
cell colony formation is evaluated in the presence of 7
cytokines, virtually every colony is different in gross
colony morphology or in the type or quantity of different
lineages within a colony. Other parameters of stem cell
function show similar heterogeneity. This is to be ex-
pected but highlights the meaninglessness of calls for
carrying out stem cell studies on a clonal basis. This has
been particularly prominent in plasticity studies. In fact,
due to the noted heterogeneity and the lability of these
cells, the most meaningful studies will, of necessity, be
on a population basis, not on a single cell basis. The latter
mainly provide information about the intrinsic heteroge-
neity of the population under study.
Implications of the continuum model
The continuum model is compatible with the great bulk
of published literature on stem/progenitor cells, but it
puts the system in a different context. The model strong-
ly implies that reductionist approaches to defining the
stem cell will be misleading. Rather, stem/progenitor
cells will have to be studied on a population basis in
order to understand their regulation. 
The myriad of different stem cell types which have
been reported are probably explained by the continually
changing surface phenotype of these cells. Thus, one
may see Sca-1+ mpl+ cells at one point in time, endo-
glin+ CD34- cells at another or even CD4+ CD34+, c-kit
positive at another point in time while, in fact, these are
all the same cell, simply changing reversibly their sur-
face phenotype.
In a similar vein, a highly purified population of
marrow stem cells such as LRH may at one certain
phase of cell cycle be predominantly engraftable stem
cells, while at another time point the phenotype may
be predominantly that of progenitors. In fact, the pro-
genitors and the apparently more primitive engraft-
able stem cell may be the same cell in different
functional states.
There have been elegant and highly ordered tran-
scriptional profiles for different levels of the stem/pro-
genitor cell hierarchy. The continuum proposes that
these do not exist, but that the profiles are continuously
Fig. 1. The continuum model of stem cell biology
Hierarchy continuum stem cell cycle progenitor 189
Megakaryocyte differentiation
Long-term
engraftment
Lung cell
differentiation
Surface epitotpes,
transcriptional
regulators, global
gene expression
and different
functional
parameters
continuously and
reversibly change as
cells transit cell
cycle
changing and represent fluctuating windows of tran-
scriptional opportunity.
These considerations, backed by the data presented
above, indicate that the potential to differentiate into
different tissues is continuously changing and, with a
synchronized stem cell population, one can discern dif-
ferentiation hot spots for specific hematopoietic or non-
hematopoietic lineages. The implications of this for
effective tissue restoration in a variety of diseases are
apparent and exciting.
Lastly, these deliberations indicate that mathematical
modeling will become more and more important in our
understanding of stem cell biology and that effective
collaboration with our computer and mathematically
conversant friends will become necessary for continued
progress in this fascinating field.
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